Rchr
J-GLOBAL ID:201601013217303360   Update date: Apr. 25, 2024

Okabe Yasutaka

Okabe Yasutaka
Research field  (1): Immunology
Research theme for competitive and other funds  (4):
  • 2022 - 2027 The roles of pleural adipose tissue-derived factors in the regulation of innate B-cell niche and airway immune responses
  • 2019 - 2023 新規中皮細胞が制御する体腔免疫系
  • 2019 - 2022 Molecular basis for tissue macrophage diversity
  • 2016 - 2019 Mechanisms of tissue macrophage development
Papers (21):
  • Yasutaka Okabe. Development and organization of omental milky spots. Immunological Reviews. 2024
  • Domnica Luca, Sumin Lee, Keiji Hirota, Yasutaka Okabe, Junji Uehori, Kazushi Izawa, Anna-Lisa Lanz, Verena Schütte, Burcu Sivri, Yuta Tsukamoto, et al. Aberrant RNA sensing in regulatory T cells causes systemic autoimmunity. Science Advances. 2024. 10. 9
  • Tomomi Yoshihara, Yasutaka Okabe. Aldh1a2 + fibroblastic reticular cells regulate lymphocyte recruitment in omental milky spots. Journal of Experimental Medicine. 2023. 220. 5
  • Yasutaka Okabe. [Macrophage plasticity in homeostasis and diseases]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2022
  • Yasutaka Okabe. Immune Niche Within the Peritoneal Cavity. Current topics in microbiology and immunology. 2021. 123-134
more...
MISC (4):
Books (9):
  • 臨床免疫・アレルギー科
    科学評論社 2023
  • 炎症と免疫
    先端医学社 2021
  • 細胞
    ニューサイエンス社 2018
  • メディカル・サイエンス・ダイジェスト
    ニューサイエンス社 2018
  • 医学のあゆみ 自然免疫の最前線
    医歯薬出版株式会社 2018
more...
Lectures and oral presentations  (16):
  • Non-classical lymphoid organ formation in body cavity
    (2023)
  • Macrophage Plasticity in Homeostasis and Diseases
    (2021)
  • Regulation of Body Cavity Immunity
    (The 73rd Annual Meeting of the Japan Society for Cell Biology 2021)
  • 組織マクロファージの生物学
    (神戸大学医学研究科シグナル伝達医学研究展開センターセミナー 2019)
  • 免疫の『場』としての脂肪組織
    (第40回 日本炎症・再生医学会 2019)
more...
Awards (2):
  • 2015 - 文部科学大臣表彰若手科学者賞
  • 2006 - 山村賞
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page